NEW YORK, April 1 - Lynx Therapeutics and Aventis CropScience will co-develop and commercialize an assay based on Lynx's bead-based technologies, the companies said today.
 
Terms of the collaboration, which extends by five years a deal the firms inked in March 1999 that gave the German ag-bio firm access to Lynx's genomics-discovery services, will give the companies joint ownership of the assay technology.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.